相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes
Guimiao Lin et al.
BIOMATERIALS SCIENCE (2014)
Targeting apoptosis pathways in pancreatic cancer
Alexander Arlt et al.
CANCER LETTERS (2013)
eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation
Chao Xu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells
Kyohei Yoshikawa et al.
EXPERIMENTAL CELL RESEARCH (2013)
Targeting the RAS oncogene
Asami Takashima et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Synthesis of Cationic Polylactides with Tunable Charge Densities as Nanocarriers for Effective Gene Delivery
Charles H. Jones et al.
MOLECULAR PHARMACEUTICS (2013)
Delivery materials for siRNA therapeutics
Rosemary Kanasty et al.
NATURE MATERIALS (2013)
Diversifying microRNA sequence and function
Stefan L. Ameres et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Biodegradable Nanocapsules as siRNA Carriers for Mutant K-Ras Gene Silencing of Human Pancreatic Carcinoma Cells
Guimiao Lin et al.
SMALL (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Lipopolysaccharide enhances FcεRI-mediated mast cell degranulation by increasing Ca2+ entry through store-operated Ca2+ channels: implications for lipopolysaccharide exacerbating allergic asthma
Chengbin Yang et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Hyukjin Lee et al.
NATURE NANOTECHNOLOGY (2012)
Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
Meredith A. Collins et al.
PLOS ONE (2012)
Well-Defined Degradable Cationic Polylactide as Nanocarrier for the Delivery of siRNA to Silence Angiogenesis in Prostate Cancer
Chih-Kuang Chen et al.
ADVANCED HEALTHCARE MATERIALS (2012)
Special delivery: targeted therapy with small RNAs
D. Peer et al.
GENE THERAPY (2011)
Promise and Challenge of RNA Interference-Based Therapy for Cancer
Fabio Petrocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Elimination Pathways of Systemically Delivered siRNA
Yuanyu Huang et al.
MOLECULAR THERAPY (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
miR-146a Suppresses Invasion of Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
Julie Guillermet-Guibert et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion
Ying-Hui Zhi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications
Chuan Huang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo
Piotr Jasinski et al.
TRANSLATIONAL RESEARCH (2008)
Systemic siRNA delivery via hydrodynamic intravascular injection
David L. Lewis et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
K-ras as a target for cancer therapy
BB Friday et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2005)
Cell migration and invasion assays
A Valster et al.
METHODS (2005)
Molecular consequences of silencing mutant K-ras in pancreatic cancer cells:: Justification for K-ras-directed therapy
JB Fleming et al.
MOLECULAR CANCER RESEARCH (2005)
Gelatinase-mediated migration and invasion of cancer cells
M Björklund et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2005)
Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity
Y Miura et al.
CANCER LETTERS (2005)
An overview of current delivery systems in cancer gene therapy
A El-Aneed
JOURNAL OF CONTROLLED RELEASE (2004)
A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods
JC Yarrow et al.
BMC BIOTECHNOLOGY (2004)
Tumour-cell invasion and migration: Diversity and escape mechanisms
P Friedl et al.
NATURE REVIEWS CANCER (2003)
Stable suppression of tumorigenicity by virus-mediated RNA interference
TR Brummelkamp et al.
CANCER CELL (2002)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)
Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma
T Tsuchida et al.
CANCER GENE THERAPY (2000)
分享论文
